What does Acarix AB (publ) do?

Acarix AB (publ) (ACARIX.ST) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ACARIX.ST's market cap?

Acarix AB (publ) (ACARIX.ST) has a market capitalization of approximately $278.0 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does ACARIX.ST pay a dividend?

No — Acarix AB (publ) (ACARIX.ST) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is ACARIX.ST profitable?

Acarix AB (publ) (ACARIX.ST) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ACARIX.ST

Acarix AB (publ)

STO·Medical, Devices · Healthcare

kr 0.25kr 0.01+2.91%

Market capkr 278.02M·Market closed·Aug 26 2:50 PM UTC

Price Chart

kr 0.25+kr 0.01 (+2.91%)today

−82.55%CAGR −29.47%

Select date range

FromTo

Dec 19, 2016Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

ACARIX.ST does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)kr 0.10

P/E Ratio (FWD)2.47

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 5

Last Report DateAug 13

Reported vs Estimate−kr 0.01

Earnings Surprise—

FinancialsFinancials Tab

Revenuekr 9.22M

Net Income−kr 39.38M

Net Margin−427.0%

Operating Cash Flow−kr 34.77M

Capital Expenditureskr 10.42M

Free Cash Flow−kr 23.23M

Return on Equity−90.0%

Return on Invested Capital−21.3%

Net Cashkr 28.88M

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ACARIX.ST and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ACARIX.ST's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ACARIX.ST and 80,000+ other tickers.

About Acarix AB (publ)

Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.

CEO: Aamir Mahmood
Sector: Healthcare
Industry: Medical - Devices
Exchange: STO
Employees: 8
Website: www.acarix.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ACARIX.ST

What does Acarix AB (publ) do?: Acarix AB (publ) (ACARIX.ST) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ACARIX.ST's market cap?: Acarix AB (publ) (ACARIX.ST) has a market capitalization of approximately $278.0 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does ACARIX.ST pay a dividend?: No — Acarix AB (publ) (ACARIX.ST) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ACARIX.ST profitable?: Acarix AB (publ) (ACARIX.ST) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.